Roxadustat (FG-4592)

Catalog No.S1007 Batch:S100706

Print

Technical Data

Formula

C19H16N2O5
Molecular Weight 352.34 CAS No. 808118-40-3
Solubility (25°C)* In vitro DMSO 70 mg/mL (198.67 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
2.0mg/ml Taking the 1 mL working solution as an example, add 50 μL of 40 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Roxadustat (FG-4592) is an HIF-α prolyl hydroxylase inhibitor in a cell-free assay, stabilizes HIF-2 and induces EPO production. Roxadustat potentiates RSL3 induced ferroptosis. Phase 3.
In vitro

FG-4592 is an oral inhibitor of hypoxia inducible factor (HIF) prolyl hydroxylase currently in clinical development for the treatment of anemia. FG-4592 stabilizes the activities of HIF, a cytosolic transcription factor, leading to activation of the genes associated with erythropoiesis, including erythropoietin and enzymes involved in iron metabolism. [1]
In vivo

Roxadustat (50 mg/kg; i.p.; daily for 7 days) protects the survival of motor neurons and improves recovery from spinal cord injury.[2]

Protocol (from reference)

Cell Assay:

[2]
  • Cell lines

    PC12 cells

  • Concentrations

    50 μM

  • Incubation Time

    6 h

  • Method

    Cell cultures were pre-treated with FG-4592 alone or in the presence of YC-1 for 6 h and then the culture medium was replaced immediately by fresh medium with 150 mM TBHP.
Animal Study:

[2]
  • Animal Models

    Female C57BL/6 mice

  • Dosages

    50 mg/kg

  • Administration

    i.p.

Customer Product Validation

Data from [Data independently produced by , , Chem Sci, 2017, doi: 10.1039/C7SC02103H]

Data from [Data independently produced by , , Cell Physiol Biochem, 2018, 46(6):2460-2470]

Data from [Data independently produced by , , Clin Sci, 2018, 132(7):825-838]

Data from [Data independently produced by , , J Pharmacol Exp Ther, 2018, 364(1):87-96]

Selleck's Roxadustat (FG-4592) has been cited by 111 publications

Oxygen enhances antiviral innate immunity through maintenance of EGLN1-catalyzed proline hydroxylation of IRF3 [ Nat Commun, 2024, 15(1):3533] PubMed: 38670937
Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism [ Theranostics, 2024, 14(7):2856-2880] PubMed: 38773968
Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism [ Theranostics, 2024, 14(7):2856-2880] PubMed: 38773968
Single-embryo transcriptomic atlas of oxygen response reveals the critical role of HIF-1α in prompting embryonic zygotic genome activation [ Redox Biol, 2024, 72:103147] PubMed: 38593632
Total loss of VHL gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity [ Proc Natl Acad Sci U S A, 2024, 121(40):e2410356121] PubMed: 39320914
Factor inhibiting HIF negatively regulates antiviral innate immunity via hydroxylation of IKKϵ [ Cell Rep, 2024, 43(1):113606.] PubMed: 38127621
A nature-inspired HIF stabilizer derived from a highland-adaptation insertion of plateau pika Epas1 protein [ Cell Rep, 2024, 43(9):114727] PubMed: 39269902
Inhibition of OGFOD1 by FG4592 confers neuroprotection by activating unfolded protein response and autophagy after ischemic stroke [ J Transl Med, 2024, 22(1):248] PubMed: 38454480
The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome [ PLoS Pathog, 2024, 20(1):e1011917] PubMed: 38227578
FG-4592 protected haematopoietic system from ionising radiation in mice [ Immunology, 2024, 10.1111/imm.13797] PubMed: 38685744

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.